Immunotherapy Research Articles & Analysis
12 articles found
“We are excited to provide researchers with access to advanced technologies and extensive support crucial for their transformative studies.” In summary, Alfa Cytology excels in delivering vital services for cancer immunotherapy and cell therapy research, enabling scientists and researchers to push the boundaries of current ...
These trials provide patients with opportunities to participate in research aimed at discovering new therapies and improving existing treatment methods. ...
Alfa Cytology leverages state-of-the-art technologies such as genomic sequencing, bioinformatics, and advanced screening techniques to discover and develop new immunotherapies. These avant-garde solutions are built upon a profound understanding of tumor immunology and cellular signaling pathways, empowering researchers to strengthen research on ...
Immunotherapy in Leukemia Treatment Immunotherapy represents a paradigm shift in the treatment of leukemia. ...
At present, some commonly used technologies for breast cancer treatment include surgery, chemotherapy, radiation therapy, hormone therapy, targeted therapy, and immunotherapy. To deeply understand the biological characteristics of breast cancer, some CRO companies also offer modeling services (e.g., breast cancer animal models) for research. Particularly, ...
Once the target antigen is linked, researchers can begin the process of creating monoclonal antibodies that specifically bind to that antigen. ...
Because nanobodies are smaller in size and have stronger tumor tissue penetration capabilities, researchers are currently applying them to ADC drugs for the treatment of solid tumors, hoping to improve the solid tumor tissue penetration effects of current ADC drugs.Nanobody StructureGenerally, the relative molecular mass of nanobodies is about 15kDa, which is only about 1/10 of ...
Due to the important role of IL-2 and IL-2R in maintaining immune tolerance and host immunity, more and more new research is focusing on novel treatment plans for IL-2 related diseases, which is conducive to the rapid expansion of the field of immunotherapy. ...
The company has recently launched TCR-seq, a powerful service that enables rapid and efficient analysis of T-cell receptor (TCR) diversity and clonality, providing critical support for immune and cancer research. As immunotherapy gains widespread use, increasing attention is being focused on T-cell clone diversity and clonality, which is crucial for evaluating ...
The immune system was optimized over the course of centuries of evolution, and it is our greatest weapon against cancer. For many years, research focused mainly on immune response to cancer. This research has enabled a far better understanding of the key players in cancer immunology; now, the acquired knowledge can be used to better target. ...
Traditional high-throughput sequencing methods are difficult to apply to transcriptome analysis of rare circulating tumor cells, the research of the earliest differentiation characteristics of human embryogenesis, and the study of tumor non-homogeneity and microevolution. ...
The body's immune system is an effective weapon against disease, and immunotherapy of cancer cell research is the current frontier in the treatment of cancer and other diseases. Recently, researchers at Notre Dame University have identified specific features of the reaction of two distinct peptide antigens to a T-cell receptor (TCR), which ...